Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle Cell Disease: Managing Pain
source: National heart, lung and blood institute
year: 2018
summary/abstract:Currently, sickle cell disease has no widely available cure. However, if you have the disease, certain treatments can help with your pain.
Good health care is important for people who have sickle cell disease, so see your doctor regularly. Work with your doctor to create a pain control plan that makes sense for you, and carry it with you if you go to the emergency room.
· Mild pain is often treated at home. More severe pain may need to be treated in a clinic or hospital.
· Fluids can help prevent dehydration, which can worsen pain.
· Over-the-counter pain medicine can help with mild to moderate pain.
· Stronger medicines called opioids may be prescribed for more severe pain.
· Ask your doctor about a medicine called hydroxyurea that may decrease pain episodes. Some patients may benefit from taking a new medicine called L-glutamine oral powder. Talk to your doctor to determine if this medicine is right for you.
· Other methods for managing pain include getting physical therapy, using a heating pad, or engaging in activities, such as listening to music, that help distract you from the pain.
read moreRelated Content
-
Acute Vaso-Occlusive Pain is Temporally Associated With the Onset of Menstruation in Women With Sickle Cell DiseaseBackground: Acute vaso-occlusive pain e...
-
APS Scientific Meeting 2019The American Pain Society will hold its ...
-
Sickle cell disease in the emergency departmentAcute painful episodes are the most comm...
-
Vaso occlusive Crisis Pain Assessment & Managementhttps://www.youtube.com/watch?time_conti...
-
Methadone provides pain relief for kids with sickle cellMany children with sickle cell disease e...
-
New Research Suggests SANGUINATE™ Reduces the Number of Sickled Red Blood Cells in Patients with Vaso-Occlusive Cr...SANGUINATE™, the only investigational ...
-
Phase 1 trial to test under-the-skin injection of sevuparin in sickle cell patientsModus Therapeutics is going to launch ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.